0 projects

IS-BILAT-Mobilitet Norge-USA /Canada

Transglutaminase 2 as therapeutic target in celiac disease

Celiac disease is caused by an aberrant immunological response towards the environmental antigen gluten. Modification of gluten peptides (deamidation) by the enzyme transglutaminase 2 (TG2) is pivotal to initiate and maintain a pathological immune respons e. Inhibition of TG2 activity is therefor...

Awarded: NOK 55,000

Project Period: 2010-2010

Location: Oslo

INT-BILAT-BILAT-ordningen

USA: bilateralt samarbeid for å utvikle fagområdet Tissue engineering

Bakgrunn for fagfeltet: Fagområdet Tissue engineering (på norsk kanskje best oversatt med vevsregenerativ behandling) beskriver det forskningsarbeidet som tar sikte på å (gjen)oppbygge vev. Dette kan dreie seg om vev som ikke har eksistert, eller vev som har vært normalt men som har blitt skade...

Awarded: NOK 0.15 mill.

Project Period: 2007-2008

Location: Oslo

INT-BILAT-BILAT-ordningen

USA - Bilateral projects between Bogen lab and various laboratories associated with Harvard Medical School

The applicant, Bjarne Bogen, had a 6 months sabbatical stay at Dana Farber Cancer Institute/ Harvard Medical school Sept 1st 2004 to March 1st 2005. During this period he established a number of bilateral collaborations with the following laboratories: 1) Klaus Rajewsky (Center for Blood Researc...

Awarded: NOK 0.15 mill.

Project Period: 2006-2007

Location: Oslo

IS-AUR-Samarb.progr. Norge Frankrike

Lie, Benedicte A Aur06/07-10 Utbet for 06: 41000 Utbet for 07: 30000 (av 06 budsj)

...

Awarded: NOK 71,000

Project Period: 2006-2008

Location: Oslo